RxDoctor Payments DataLook up a doctor →

Farhan Sheikh, MD

Neurology · Ottawa, KSNPI 1265551873

Payments from drug & device makers

$12,432in general payments, 2019–2025

Across 811 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$926
  • Neurocrine Biosciences, Inc.$653
  • Biogen$562
  • EMD Serono, Inc.$499
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.85$1,307
AbbVie(2 entities)135$1,243
Teva Pharmaceuticals USA, Inc.83$926
Neurocrine Biosciences, Inc.36$653
Biogen35$562
EMD Serono, Inc.32$499
MDD US Operations, LLC26$420
SK Life Science, Inc.21$400
Eisai Inc.20$354
Amgen21$340
Lundbeck LLC16$291
Abbott15$274
Amneal Pharmaceuticals LLC23$259
Adamas Pharmaceuticals, Inc.18$252
AstraZeneca(2 entities)11$249
Acadia Pharmaceuticals Inc14$247
Bristol Myers Squibb12$236
Jazz Pharmaceuticals Inc.12$233
Sanofi12$231
Avion Pharmaceuticals4$217
Argenx US, Inc.10$212
Supernus Pharmaceuticals, Inc.12$197
Genentech USA, Inc.10$195
Kyowa Kirin, Inc.10$188
Upsher-smith Laboratories LLC10$185
Nevro Corp.3$181
Novartis9$172
Biohaven Pharmaceuticals, Inc.13$158
Lilly USA, LLC9$158
Johnson & Johnson7$136
Pfizer8$134
Biohaven Pharmaceutical Holding Company Ltd.14$117
Acorda Therapeutics, Inc8$115
Otsuka America Pharmaceutical, Inc.5$108
Neurelis, Inc.5$104
Livanova USA, Inc.4$82
Axsome Therapeutics, Inc.4$69
Novo Nordisk3$62
Aucta Pharmaceuticals, Inc.3$56
Catalyst Pharmaceuticals, Inc.3$56
Harmony Biosciences LLC2$46
Sumitomo Pharma America, Inc.2$46
Cycle Pharmaceuticals Inc2$42
Corium, LLC2$40
ANI Pharmaceuticals, Inc.2$38
Avanir Pharmaceuticals, Inc.3$37
Mallinckrodt Hospital Products Inc.2$36
Grifols USA, LLC1$33
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$30
Zyla Life Sciences, Inc.2$29
Azurity Pharmaceuticals, Inc.1$24
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$23
Xeris Pharmaceuticals, Inc.1$23
GSK1$21
Aprecia Pharmaceuticals, LLC1$16
GE HealthCare1$15
Exact Sciences1$14
Electronic Waveform Lab, Inc.1$13
Mallinckrodt Enterprises LLC1$13
Nestle Healthcare Nutrition Inc.1$13

How this compares

$12,432 in reported general payments places this provider in the 75th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Medicare billing

Part B allowed, 2024
$18,612
Medicare patients
116
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Ottawa

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →